Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAb in their systems.

Background: Mouse models of colitis and cancer are indispensable for our understanding of the pathogenesis of these diseases. In the past, mice had to be sacrificed in order to analyse colitis ...

Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...

Assessment of CIT-drugs MoA with in vivo and 3D in vitro imaging [abstract]. In: Proceedings of the AACR IO Conference: Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through ...

The researchers designed an efficient approach for fabricating engineered Pts-based nano-aircraft carriers with graded drug delivery and ECM degradation for precise cancer chemoimmunotherapy.

The following is a summary of "Role of MUC16 in tumor biology and tumor immunology in ovarian cancer," published in the ...

They are utilised for an increasing number of commercial advanced therapy technologies, from chimeric antigen receptor (CAR) T-cell therapies to ex vivo gene therapies and, earlier last year ...

The following is a summary of "Unveiling the oncogenic role of SLC25A13: a multi-omics pan-cancer analysis reveals its impact ...

Identification of pathway provides mechanistic insights into the anti-metastatic effects of aspirin, as a potential basis for ...

LIfT BioSciences Secures Another Landmark US Patent, Strengthening Its Position as the World Leader in Neutrophil ...